360 related articles for article (PubMed ID: 28610993)
1. Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia.
Cordaro M; Impellizzeri D; Siracusa R; Gugliandolo E; Fusco R; Inferrera A; Esposito E; Di Paola R; Cuzzocrea S
Toxicol Appl Pharmacol; 2017 Aug; 329():231-240. PubMed ID: 28610993
[TBL] [Abstract][Full Text] [Related]
2. A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation.
Esposito E; Impellizzeri D; Bruschetta G; Cordaro M; Siracusa R; Gugliandolo E; Crupi R; Cuzzocrea S
Eur J Pharmacol; 2016 Jul; 782():107-18. PubMed ID: 27095683
[TBL] [Abstract][Full Text] [Related]
3. Palmitoylethanolamide and Polydatin combination reduces inflammation and oxidative stress in vascular injury.
Gugliandolo E; Fusco R; Biundo F; D'Amico R; Benedetto F; Di Paola R; Cuzzocrea S
Pharmacol Res; 2017 Sep; 123():83-92. PubMed ID: 28676456
[TBL] [Abstract][Full Text] [Related]
4. Auraptene nanoparticles ameliorate testosterone-induced benign prostatic hyperplasia in rats: Emphasis on antioxidant, anti-inflammatory, proapoptotic and PPARs activation effects.
Almukadi H; Eid BG; Shaik RA; Abdel-Naim AB; Esmat A
Biomed Pharmacother; 2021 Nov; 143():112199. PubMed ID: 34649341
[TBL] [Abstract][Full Text] [Related]
5. Asteris Radix et Rhizoma suppresses testosterone-induced benign prostatic hyperplasia in rats by regulating apoptosis and inflammation.
Rho J; Seo CS; Park HS; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ
J Ethnopharmacol; 2020 Jun; 255():112779. PubMed ID: 32209388
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats.
Jeon WY; Kim OS; Seo CS; Jin SE; Kim JA; Shin HK; Kim YU; Lee MY
BMC Complement Altern Med; 2017 Aug; 17(1):384. PubMed ID: 28774334
[TBL] [Abstract][Full Text] [Related]
7. Effects of different natural extracts in an experimental model of benign prostatic hyperplasia (BPH).
Paterniti I; Campolo M; Cordaro M; Siracusa R; Filippone A; Esposito E; Cuzzocrea S
Inflamm Res; 2018 Jul; 67(7):617-626. PubMed ID: 29679313
[TBL] [Abstract][Full Text] [Related]
8. Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase.
Youn DH; Park J; Kim HL; Jung Y; Kang J; Jeong MY; Sethi G; Seok Ahn K; Um JY
Oncotarget; 2017 Feb; 8(6):9500-9512. PubMed ID: 27880726
[TBL] [Abstract][Full Text] [Related]
9. Quisqualis indica Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis.
Ub Wijerathne C; Park HS; Jeong HY; Song JW; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Yeon SH; Kwun HJ
Biol Pharm Bull; 2017 Dec; 40(12):2125-2133. PubMed ID: 28943529
[TBL] [Abstract][Full Text] [Related]
10. Kolaviron modulates angiogenesis, apoptosis and inflammatory signaling in rat model of testosterone propionate-induced benign prostate hyperplasia.
Farombi EO; Ajayi BO; Opata EK; Fafioye AO; Akinade AT
Inflammopharmacology; 2023 Aug; 31(4):2121-2131. PubMed ID: 36881348
[TBL] [Abstract][Full Text] [Related]
11. Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia.
D'Amico R; Genovese T; Cordaro M; Siracusa R; Gugliandolo E; Peritore AF; Interdonato L; Crupi R; Cuzzocrea S; Di Paola R; Fusco R; Impellizzeri D
Antioxidants (Basel); 2021 Jun; 10(7):. PubMed ID: 34202665
[TBL] [Abstract][Full Text] [Related]
12. Paljung-San, a traditional herbal medicine, attenuates benign prostatic hyperplasia in vitro and in vivo.
Park E; Lee MY; Jeon WY; Seo CS; You S; Shin HK
J Ethnopharmacol; 2018 May; 218():109-115. PubMed ID: 29501675
[TBL] [Abstract][Full Text] [Related]
13. Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulating inflammatory responses, reducing oxidative stress and anti-proliferative.
Yang X; Yuan L; Xiong C; Yin C; Ruan J
J Ethnopharmacol; 2014 Nov; 157():105-13. PubMed ID: 25260581
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of testosterone induced benign prostatic hyperplasia by Prunus species.
Jena AK; Vasisht K; Sharma N; Kaur R; Dhingra MS; Karan M
J Ethnopharmacol; 2016 Aug; 190():33-45. PubMed ID: 27235020
[TBL] [Abstract][Full Text] [Related]
15. Periodontitis Exacerbates Benign Prostatic Hyperplasia through Regulation of Oxidative Stress and Inflammation.
Fang C; Wu L; Zhao MJ; Deng T; Gu JM; Guo XP; Li C; Li W; Zeng XT
Oxid Med Cell Longev; 2021; 2021():2094665. PubMed ID: 34707774
[TBL] [Abstract][Full Text] [Related]
16. Rice Hull Extract Suppresses Benign Prostate Hyperplasia by Decreasing Inflammation and Regulating Cell Proliferation in Rats.
Kim CY; Chung KS; Cheon SY; Lee JH; Park YB; An HJ
J Med Food; 2016 Aug; 19(8):746-54. PubMed ID: 27441629
[TBL] [Abstract][Full Text] [Related]
17. Ulmus macrocarpa Hance improves benign prostatic hyperplasia by regulating prostatic cell apoptosis.
Rho J; Seo CS; Park HS; Wijerathne CU; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ
J Ethnopharmacol; 2019 Apr; 233():115-122. PubMed ID: 30508623
[TBL] [Abstract][Full Text] [Related]
18. The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats.
Impellizzeri D; Ahmad A; Bruschetta G; Di Paola R; Crupi R; Paterniti I; Esposito E; Cuzzocrea S
Eur J Pharmacol; 2015 Aug; 761():28-35. PubMed ID: 25934566
[TBL] [Abstract][Full Text] [Related]
19. The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice.
Impellizzeri D; Peritore AF; Cordaro M; Gugliandolo E; Siracusa R; Crupi R; D'Amico R; Fusco R; Evangelista M; Cuzzocrea S; Di Paola R
FASEB J; 2019 Oct; 33(10):11364-11380. PubMed ID: 31344333
[TBL] [Abstract][Full Text] [Related]
20. Diacerein ameliorates testosterone-induced benign prostatic hyperplasia in rats: Effect on oxidative stress, inflammation and apoptosis.
El-Sherbiny M; El-Shafey M; El-Din El-Agawy MS; Mohamed AS; Eisa NH; Elsherbiny NM
Int Immunopharmacol; 2021 Nov; 100():108082. PubMed ID: 34450401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
